Industries > Pharma > Global Stem Cell Technologies and Applications Market 2020-2030

Global Stem Cell Technologies and Applications Market 2020-2030

By Applications (Therapeutics (Cancer, Cardiovascular, CNS, Other Disease Areas), Non-Therapeutics), by Region (North America, Europe, Asia Pacific, Rest of the World) and Key Companies analysis in Stem Cell Technologies

PUBLISHED: 24 March 2020
PAGES: 311
PRODUCT CODE: PHA0731

Clear
WOOCS 2.2.1

covid-19

The global stem cell technologies and applications market is estimated to have reached US $17,791.8 million 2020 and is expected to grow at a CAGR of 11.8% in the first half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 311-page report you will receive 165 charts– all unavailable elsewhere.

The 311-page report provides clear detailed insight into the global stem cell technologies and applications market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Stem Cell Technologies and Applications Market forecasts from 2020-2030

• Global Stem Cell Technologies and Applications submarket forecasts from 2020-2030:
• Cancer treatment
• Cardiovascular therapy
• CNS
• Other therapies
• Non-therapeutic applications

• Individual revenue forecast to 2030 for selected top products:
• MSC-100-IV (Mesoblast)
• Hearticellgram-AMI (Pharmicell)
• CardioRel (Reliance Life Sciences)
• Osteocel Plus (NuVasive)
• Trinity Evolution and Elite (Orthofix)
• CARTISTEM (MEDIPOST)

• Analysis of the most promising pipeline therapies in each therapeutic segment

• Discussion on regulatory environments and developments in the US, Japan, Europe and other leading countries

• Analysis of what drives and restrains the market

• This study also discusses other influences on that field, including these:
• Haematopoietic stem cell transplantation (HSCT)
• Embryonic stem cells (ESCs), induced pluripotent adult (IPSCs) and parthenogenetic cells
• Uses for umbilical cord blood and related technologies, including cellular and blood banking
• Agents for osteogenesis and treating autoimmune conditions
• Applications in cell-based assays, diagnostics and drug development.

• Key questions answered by this report:
• What is the size of the total stem cells market, and how will the market evolve between 2020 and 2030?
• How will the main segments within the overall stem cells market develop between 2020-2030?
• What are the main drivers and restraints that will shape the overall stem cells market, and its individual segments over the next ten years?
• What is the state of stem cell research in the different therapeutic segments?
• What are some of the most prominent companies within this space, and what are their latest developments?
• What are the most promising pipeline therapies in each therapeutic segment?
• What are the revenue prospects for some of the stem cell therapies which have already been approved?
• What are the main strengths, weaknesses, opportunities and threats for the stem cell market?
• What are the main social, technological, economic and political factors that influence this market?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Stem Cell Technologies and Applications Market. You find data, trends and predictions.

Buy our report today Global Stem Cell Technologies and Applications Market Analysis : By Applications (Therapeutics (Cancer, Cardiovascular, CNS, Other Disease Areas), Non-Therapeutics), by Region (North America, Europe, Asia Pacific, Rest of the World) and Company Profiling.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Stem Cell Technologies and Applications Market 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Stem Cell Technologies and Applications Market 2020-2030


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories

Category